Both examples provide a scientific opportunity to modify the IBD ISC genetic susceptibility (for example, in NOD2 mutations in Paneth cell dysfunction in CD)59 and to develop a human IBD epithelial experimental model with the ability to perturb and interrogate function with gene editing.60 Here, NOD2 is linked to inflammatory bowel disease.